COVID-19 research opportunity for individuals with Down syndrome
We are seeking people with Down syndrome who had COVID-19 to participate in a new study
Seeking passionate, driven scientists to join our team
Make a difference in the lives of people with Down syndrome with us
Science reports on Crnic Institute and others' research on COVID-19 in Down syndrome
COVID-19 is 10 times deadlier for people with Down syndrome, raising calls for early vaccination
Helping lead the NIH data coordinating center for Down syndrome research
Our scientists, data analysts, and administrators have teamed up with Children's Hospital of Philadelphia and Sage Bionetworks for this new initiative
Research opportunity for people with Down syndrome who have an immune skin condition
One of our newest research initiatives is an NIH-funded clinical trial testing the safety and efficacy of a drug called tofacitinib
We use state-of-the-art, transformational research platforms to decipher the unique biology and disease spectrum caused by trisomy of chromosome 21.
Our ultimate goal is to enable precision medicine approaches to improve health outcomes in Down syndrome, including the development of new diagnostic and therapeutic tools.
Dr. Roede shows that dermal fibroblasts have a muted COX2 response in Down syndrome
Science reports on Crnic Institute and others' research on COVID-19 in Down syndrome, raising calls for early vaccination
Italian National Institute for Infectious Diseases describes COVID-19 pneumonia in two patients with Down syndrome
Crnic scientists show JAK1 inhibition normalizes damaging immune response in mouse model of Down syndrome
We are the largest geographical cluster of Down syndrome researchers in the world
Comprised of over 50 Principal Investigators and countless more contributing scientists from across the University of Colorado campuses, our researchers bring expertise from a variety of fields.
Together, we are working to decipher the complex mechanisms and multi-faceted health impacts of trisomy 21.
